Preliminary experiments suggest conolidine may perhaps inhibit unique ion channels, minimizing neuronal excitability and restricting ache signals. This mechanism is especially pertinent in neuropathic agony, where abnormal signaling brings about persistent discomfort. On top of that, conolidine appears to affect G protein-coupled receptor (GPCR) pa